Homology Medicines, Inc.(NASDAQ : FIXX)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||-0.37%||8.00||0.7%||$559.23m|
|GILD||Gilead Sciences, Inc.||1.67%||66.87||1.0%||$470.50m|
|REGN||Regeneron Pharmaceuticals, Inc.||1.61%||502.60||2.7%||$458.74m|
|VRTX||Vertex Pharmaceuticals, Inc.||-0.77%||219.39||1.9%||$388.60m|
|ALXN||Alexion Pharmaceuticals, Inc.||3.90%||163.68||2.0%||$348.10m|
|EXAS||EXACT Sciences Corp.||-0.37%||130.04||18.4%||$186.19m|
|NBIX||Neurocrine Biosciences, Inc.||1.66%||96.58||4.9%||$179.73m|
|CRSP||CRISPR Therapeutics AG||-4.27%||118.56||0.6%||$166.57m|
Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the design and development of treatments to address rare diseases at the genetic level. It develops genetic medicines by translating proprietary, next generation gene editing, and gene therapy technologies into novel treatments for patients with rare diseases. The company was founded by Saswati Chatterjee in 2015 and is headquartered in Bedford, MA.